The National Centre for Bowel Research and Surgical Innovation will enable Bowel & Cancer Research to pursue its vision, that:
No-one should die of bowel cancer, have to live with chronic bowel disease or face life with a permanent stoma.
In pursuit of this vision, Bowel & Cancer Research articulates its mission:
“We aim to deliver our vision by funding scientific and clinical research to save lives and improve the quality of life of individuals with bowel cancer or other bowel diseases. We support ways that involve the public in the design and delivery of research.
We wish to raise awareness of bowel cancer and other bowel diseases, to improve people’s knowledge of symptoms and break down taboos.”
From the world class facilities of the National Centre for Bowel Research and Surgical Innovation, Bowel & Cancer Research supports research into bowel cancer, chronic diseases (e.g.colitis and Crohn’s Disease) and chronic symptoms (e.g. Irritable Bowel Syndrome). It has a special interest in supporting surgical innovations intended to reduce the numbers of people who need to rely upon a stoma. Research responding to these diseases falls into the following areas:
Experimental medicine – investigation in humans to identify the cause of disease and to test the validity and importance of new discoveries and treatments.
Outcomes based research – clinical trials of novel interventions and surgical procedures to save lives and improve quality of life of people with chronic disease.
Innovation – in diagnostics and surgical techniques to better treat patients, save lives and improve the quality of people’s lives.
For more information on how and what we fund, download our research strategy.
Bowel & Cancer Research is a member of the Association of Medical Research Charities (AMRC). It supports the AMRC position statement on the use of animals in medical research.
Bowel & Cancer Research funds two programmes, one a small grants programme of up to £50,000 per award for proof-of-principle studies leading to the collation of primary data for major applications. The other programme is a PhD Studentship programme for applications up to £75,000 over 3 years.
Bowel & Cancer Research is an NIHR non-commercial partner. As such any studies funded by the charity are automatically eligible for NIHR Clinical Research Network (CRN) support and therefore entitled to:
- Use the NIHR Coordinated System for gaining NHS Permissions (NIHR CSP) which is accessed via the Integrated Research Application System (IRAS)
- Access NHS support via the NIHR Clinical Research Network
Preliminary application form (for first stage small grant applications)
Full application form (for final stage small grant applications)
Application form (for PhD studentship applications)
Please visit our Support Us pages if you’re interested in supporting Bowel & Cancer Research to fund ground breaking research.
If you are a member of the public, a patient or a carer and would like to be involved in shaping our research visit our Be part of it section to join online.
For any questions about our funding programmes or our public involvement programme contact Deborah Gilbert
* 3* refers to quality of research which is internationally excellent in terms of originality, significance and rigour but nonetheless falls short of the highest standards of excellence, while 4* refers to quality of research which is world-leading in terms of originality, significance and rigour. The Blizard Institute returned in hospital-based clinical subjects.
* The RAE, which happens around every 5 years, is the major activity undertaken by the 4 central funding bodies to determine the quality of research output in higher education institutions across the UK. Previous RAEs have taken place in 1986, 1989, 1992, 1996 and 2001.